Type I CD36 deficiency in hematologic disorder.
نویسندگان
چکیده
We report a 64 year old man with type I CD36 deficiency. He diagnosed as having diffuse large B cell nonHodgkin’s lymphoma (NHL) and treated with chemotherapy and radiation. He had no history of previous blood transfusions. His electrocardiogram (ECG) and echocardiogram were almost normal. However, I-βmethyl-iodophenyl pentadecanoic acid (BMIPP) cardiac scintigraphy showed complete absence of BMIPP accumulation in the heart (Figure 1). Flow cytometry analysis revealed absence of CD36 on the monocytes and platelets (Figure 2), suggesting the diagnosis of type I CD36 deficiency, as well as NHL. In patients with type I CD36 deficiency, immunization with CD36 antigen by transfusion, could produce anti-CD36 antibody, and potentially lead to platelet transfusion refractoriness or posttansfusion purpura. When transfusion lead to platelet transfusion refractoriness or posttansfusion purpura, we must take Type I CD36 deficiency into consideration.
منابع مشابه
Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency.
CD36 is an 88 kDa glycoprotein IV expressed in platelets, monocytes, erythroblasts, capillary endothelial cells, and mammary epithelial cells. CD6 was reported to be a receptor for collagen, thrombospondin, P falciparum infected red blood cells, apoptotic neutrophils, oxidised low density lipoproteins, and as a transporter for long chain fatty acids. CD36 serves many functions in coagulation, h...
متن کاملStudies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.
CD36 (also known as GPIV) deficiency is known to be responsible for the production of anti-Nak(a) antibodies in different clinical settings such as fetal/neonatal alloimmune thrombocytopenia (FNAIT), platelet transfusion refractoriness (PTR) and post-transfusion purpura (PTP). However, no data regarding the relevance of CD36 immunisation is currently available for China. In this study, healthy ...
متن کاملLETTER TO JMG Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency
CD36 is an 88 kDa glycoprotein IV expressed in platelets, monocytes, erythroblasts, capillary endothelial cells, and mammary epithelial cells. CD6 was reported to be a receptor for collagen, thrombospondin, P falciparum infected red blood cells, apoptotic neutrophils, oxidised low density lipoproteins, and as a transporter for long chain fatty acids. CD36 serves many functions in coagulation, h...
متن کاملMolecular Basis of CD 36 Deficiency
CD36 deficiency is divided into two subgroups: neither platelets nor monocytes express CD36 (type I deficiency), and monocytes express CD36 in spite of the lack of platelet CD36 (type II deficiency). We have already demonstrated that a 478C--T substitution (proline90serine) in platelet CD36 cDNA predominates in type II deficiency (Kashiwagi, H., S. Honda, Y. Tomiyama, H. Mizutani, H. Take, Y. H...
متن کاملElevated plasma plasminogen activator inhibitor-1 in CD36 deficiency.
CD36 is a fatty acid transporter expressed in various tissues including adipose, heart, and skeletal muscle tissues. The elevated fasting triglyceride levels,intermediate-density lipoprotein cholesterol levels, and postprandial hyperlipidemia observed in human CD36 deficiency have been suggested as being due to abnormal fatty acid metabolism and insulin resistance (1,2). Lipid abnormalities and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Haematologica
دوره 89 8 شماره
صفحات -
تاریخ انتشار 2004